Peptide Therapeutics Forum 2022
at University Hospital Basel
August 25-26 2022
Peptide Therapeutics Forum 2022
at University Hospital Basel
Prof. Beatriz Garcia De la Torre, University of KwaZulu-Natal, ZAF
Dr. John Lopez, Novartis, Basel
«Beyond the application of RI as PAT in solid-phase synthesis»
Dr. Paul Beswick, Bicycle Therapeutics, UK
«Bicycles® (bi-cyclic peptides) as novel therapeutics to treat antimicrobial infection»
Prof. Ali Azhdarinia, University of Texas, US
«Fluorescent peptide conjugates for intraoperative imaging»
Prof. Gaurav Bhardwaj, University of Washington, US
«Computational peptide design for target therapeutics»
Prof. Ashraf Brik, Technion-Israel Institute of Technology, ISR
«Modulating the Ubiquitin System with Cyclic Peptides: Chemistry and Biology»
Prof. Frank Kirchhoff, University of Ulm, DEU
«Peptidic fusion inhibitors for SARS Cov 2»
Dr. Søren Østergaard, Novo Nordisk, DNK
«Designing potent and selective Y2 agonists»
Prof. William D. Lubell, University of Montreal, CAN
«Inflammation modulation by peptide conformation demarcation»
Dr. Dana Ault-Riche, Maastricht University, NL
«Non-immunogenic synthetic proteins composed of D-amino acids potently inhibit tumor growth»
Dr. Rami Hannoush, US Ventures, Mubadala Capital, San Francisco, US
«Engineered peptide agonists for cellular reprogramming and tissue regeneration»